Skip to Content

Optimal Therapy for Esophageal Cancer Feasible in Fit Elderly

FRIDAY, Feb. 26, 2021 -- Patients 70 years and older with locally advanced esophageal or esophagogastric junction (EGJ) cancer should be considered for optimal, potentially curative therapy, including neoadjuvant chemoradiotherapy and surgical resection, according to a study published online Feb. 4 in the Journal of the American College of Surgeons.

W. Peter Sawyer, M.D., from the Ochsner Clinic Foundation in New Orleans, and colleagues used data from 405 consecutive patients with esophageal or EGJ cancer (2004 through 2019) to assess the risks of multimodality therapy with curative intent, including surgical resection, in the elderly population (≥70 years of age).

The researchers found that 188 younger patients (mean age, 59 years) and 94 older patients (mean age, 74 years) received neoadjuvant chemoradiotherapy and surgical resection for stage II and higher cancer. In the older group, preoperative American Society of Anesthesiologist class and Charlson Comorbidity Index scores were significantly worse. Postoperatively, patients in the older group more often developed atrial fibrillation and urinary retention. However, the older and younger groups had similar rates for postoperative Clavien-Dindo complication severity scores of 3 or higher and perioperative mortality, as well as similar lengths of stay. The age-adjusted survival rate at five years was 44.8 percent for the older group and 39 percent for the younger group.

"Even though our results are not randomized, these findings provide a strong indication that declining to perform a surgical resection significantly reduces the likelihood of a cure for older patients who are deemed fit for the operation," a coauthor said in a statement.

Abstract/Full Text (subscription or payment may be required)

© 2021 HealthDay. All rights reserved.

Read this next

COVID-19 Infection May Up Mortality in Surgical Patients

TUESDAY, April 13, 2021 -- COVID-19 infection is an independent risk factor for surgical mortality, according to a research letter published online April 12 in JAMA Network...

First U.S. Trachea Transplant Patient Breathing Freely

TUESDAY, April 6, 2021 -- A woman who received the first trachea transplant in the United States could be a model for other patients, including those with birth defects, those...

Adjuvant Nivolumab Beneficial in Esophageal, GE Junction Cancer

THURSDAY, April 1, 2021 -- Among patients with resected esophageal or gastroesophageal junction cancer who have received neoadjuvant chemoradiotherapy, disease-free survival is...

More News Resources

Subscribe to our Newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.